GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Net Income Including Noncontrolling Interests

Sci Pharmtech (TPE:4119) Net Income Including Noncontrolling Interests : NT$276 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Sci Pharmtech's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was NT$45 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was NT$276 Mil.

Sci Pharmtech Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Sci Pharmtech's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Net Income Including Noncontrolling Interests Chart

Sci Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 571.10 360.12 55.70 308.78 294.72

Sci Pharmtech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.44 199.52 35.38 -3.61 44.51

Sci Pharmtech Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$276 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Sci Pharmtech (TPE:4119) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TPE:4746 TPE:1720 ROCO:6576 ROCO:6932 TPE:3705 ROCO:6785 TPE:1701 ROCO:4114 ROCO:4132 ROCO:4166 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Website
http://www.sci-pharmtech.com.tw
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines